Tailored Liposomal Nanomedicine Suppresses Incomplete Radiofrequency Ablation‐Induced Tumor Relapse by Reprogramming Antitumor Immunity DOI Open Access
Duo Wang, Tianqi Nie, Yifei Fang

и другие.

Advanced Healthcare Materials, Год журнала: 2025, Номер unknown

Опубликована: Фев. 17, 2025

Radiofrequency ablation (RFA), a thermoablative treatment for small hepatocellular carcinoma (HCC), has limited therapeutic benefit advanced HCC patients with large, multiple, and/or irregular tumors owing to incomplete RFA (iRFA) of the tumor mass. It is first identified that iRFA-treated exhibited increased pyruvate kinase M2 (PKM2) expression, exacerbated immunosuppression featured infiltration suppressive immune cells and proliferation, programmed cell death ligand 1 expression cancer ultimately poor prognosis. Herein, multifunctional nanomedicine fabricated by encapsulating nanoassemblies anti-PD-L1 spermidine-grafted oxidized dextran shikonin-containing lipid bilayers reverse iRFA-induced failure. Shikonin, PKM2 inhibitor, used suppress glycolysis in cells, while spermidine are introduced collectively reprogram proliferation functions infiltrated CD8+ T lymphocytes. Combined iRFA, which promoted exposure antigens, intravenous injection liposomal SPS-NPs effectively stimulated dendritic maturation reversed immunosuppression, thus eliciting potent antitumor immunity synergistically growth residual masses lung metastasis. The as-prepared promising potentiating benefits toward through reprogramming immunosuppression.

Язык: Английский

Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy DOI Creative Commons
Yijie Wang,

Congrui Liu,

Chao Fang

и другие.

Nano-Micro Letters, Год журнала: 2024, Номер 17(1)

Опубликована: Сен. 30, 2024

Abstract Vaccinations are essential for preventing and treating disease, especially cancer nanovaccines, which have gained considerable interest recently their strong anti-tumor immune capabilities. Vaccines can prompt the system to generate antibodies activate various cells, leading a response against tumor tissues reducing negative effects recurrence risks of traditional chemotherapy surgery. To enhance flexibility targeting vaccines, nanovaccines utilize nanotechnology encapsulate or carry antigens at nanoscale level, enabling more controlled precise drug delivery responses. Cancer function by encapsulating tumor-specific tumor-associated within nanomaterials. The small size these nanomaterials allows T dendritic thereby eliciting potent response. In this paper, we focus on classification carriers roles different target clinically tested discussing strategies effectively inducing cytotoxic lymphocytes responses optimizing antigen presentation, while also looking ahead translational challenges moving from animal experiments clinical trials.

Язык: Английский

Процитировано

4

Orchestrated Copper-Loaded Nanoreactor for Simultaneous Induction of Cuproptosis and Immunotherapeutic Intervention in Colorectal Cancer DOI Creative Commons
Jiasheng Li, Shanshan Ma,

Lin Qiu-hua

и другие.

Materials Today Bio, Год журнала: 2024, Номер 29, С. 101326 - 101326

Опубликована: Ноя. 9, 2024

Ion interference, including intracellular copper (Cu) overload, disrupts cellular homeostasis, triggers mitochondrial dysfunction, and activates cell-specific death channels, highlighting its significant potential in cancer therapy. Nevertheless, the insufficient Cu ions transported by existing ionophores, which are small molecules with short blood half-lives, inevitably hamper effectiveness of cuproptosis. Herein, ESCu@HM nanoreactor, self-assembled from integration H-MnO

Язык: Английский

Процитировано

4

Photoirradiation‐ and Extracellular‐Matrix‐Encouraged Photon‐Transition Switching Regulates Spatiotemporal Sequential Photoimmunotherapy DOI Creative Commons
Hai Wang,

Feixiang Hu,

Wuyang Wei

и другие.

Small Structures, Год журнала: 2025, Номер unknown

Опубликована: Янв. 14, 2025

As two main phototherapy means, photodynamic therapy (PDT) and photothermal (PTT) have different photon‐transition avenues decided by the aggregation state of photosensitizers (PSs), thus PDT or PTT efficiency can be regulated regulating PSs aggregation. A co‐assembly formulation consisting IR780 iodide pentafluorophenyl trifluoroacetate is constructed through intermolecular interactions, followed coating with hyaluronic acid. Initially, uniform distribution favors more reactive oxygen species birth to implement when entering cells since its avenue sequential process intersystem crossing transfer–collision energy transfer predominant. After hyaluronidase laser irradiation‐induced structural collapse co‐assembly, free aggregates due hydrophobic interactions even though they are excreted out cells, then, these produce heat nonradiative relaxation execute PTT. Such a spatiotemporal PDT–PTT encourages antitumor immune responses mitigates immunosuppression, accomplishing photoimmunotherapy against breast cancer progression. Through such tumor microenvironment‐adaptable laser‐duration‐decided alteration, switching insights provided into single PSs‐mediated photoimmunotherapy.

Язык: Английский

Процитировано

0

Chimeric Antigen Receptor Cells Solid Tumor Immunotherapy Assisted by Biomaterials Tools DOI
Yujun Song, Yifan Wang,

Jianping Man

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2025, Номер unknown

Опубликована: Фев. 4, 2025

Chimeric antigen receptor (CAR) immune cell therapies have revolutionized oncology, particularly in hematological malignancies, yet their efficacy against solid tumors remains limited due to challenges such as dense stromal barriers and immunosuppressive microenvironments. With advancements nanobiotechnology, researchers developed various strategies methods enhance the CAR tumor treatment. In this Review, we first outline structure mechanism of CAR-T (T, T cell), CAR-NK (NK, natural killer), CAR-M (M, macrophage) deeply analyze potential these cells treatment they face. Next, explore how biomaterials can optimize treatments by improving microenvironment, controlling release, promoting infiltration, enhancing efficacy. Finally, summarize current solutions, emphasize effective combination therapy, look forward its future clinical application strategies. This Review provides important theoretical perspectives practical guidance for development more

Язык: Английский

Процитировано

0

Tailored Liposomal Nanomedicine Suppresses Incomplete Radiofrequency Ablation‐Induced Tumor Relapse by Reprogramming Antitumor Immunity DOI Open Access
Duo Wang, Tianqi Nie, Yifei Fang

и другие.

Advanced Healthcare Materials, Год журнала: 2025, Номер unknown

Опубликована: Фев. 17, 2025

Radiofrequency ablation (RFA), a thermoablative treatment for small hepatocellular carcinoma (HCC), has limited therapeutic benefit advanced HCC patients with large, multiple, and/or irregular tumors owing to incomplete RFA (iRFA) of the tumor mass. It is first identified that iRFA-treated exhibited increased pyruvate kinase M2 (PKM2) expression, exacerbated immunosuppression featured infiltration suppressive immune cells and proliferation, programmed cell death ligand 1 expression cancer ultimately poor prognosis. Herein, multifunctional nanomedicine fabricated by encapsulating nanoassemblies anti-PD-L1 spermidine-grafted oxidized dextran shikonin-containing lipid bilayers reverse iRFA-induced failure. Shikonin, PKM2 inhibitor, used suppress glycolysis in cells, while spermidine are introduced collectively reprogram proliferation functions infiltrated CD8+ T lymphocytes. Combined iRFA, which promoted exposure antigens, intravenous injection liposomal SPS-NPs effectively stimulated dendritic maturation reversed immunosuppression, thus eliciting potent antitumor immunity synergistically growth residual masses lung metastasis. The as-prepared promising potentiating benefits toward through reprogramming immunosuppression.

Язык: Английский

Процитировано

0